Bridgeway Capital Management’s Allena Pharmaceuticals, Inc. Common Stock ALNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-124,200
| Closed | -$29K | – | 1403 |
|
2022
Q1 | $29K | Hold |
124,200
| – | – | ﹤0.01% | 1302 |
|
2021
Q4 | $74K | Sell |
124,200
-111,800
| -47% | -$66.6K | ﹤0.01% | 1231 |
|
2021
Q3 | $213K | Sell |
236,000
-115,000
| -33% | -$104K | ﹤0.01% | 1196 |
|
2021
Q2 | $456K | Sell |
351,000
-30,200
| -8% | -$39.2K | 0.01% | 1090 |
|
2021
Q1 | $530K | Buy |
381,200
+222,400
| +140% | +$309K | 0.01% | 1073 |
|
2020
Q4 | $203K | Sell |
158,800
-2,200
| -1% | -$2.81K | ﹤0.01% | 1205 |
|
2020
Q3 | $238K | Hold |
161,000
| – | – | 0.01% | 1142 |
|
2020
Q2 | $254K | Hold |
161,000
| – | – | 0.01% | 1086 |
|
2020
Q1 | $155K | Hold |
161,000
| – | – | ﹤0.01% | 1120 |
|
2019
Q4 | $440K | Buy |
161,000
+97,800
| +155% | +$267K | 0.01% | 1033 |
|
2019
Q3 | $249K | Hold |
63,200
| – | – | ﹤0.01% | 1138 |
|
2019
Q2 | $257K | Sell |
63,200
-20,000
| -24% | -$81.3K | ﹤0.01% | 1132 |
|
2019
Q1 | $584K | Hold |
83,200
| – | – | 0.01% | 984 |
|
2018
Q4 | $453K | Hold |
83,200
| – | – | 0.01% | 1026 |
|
2018
Q3 | $894K | Buy |
83,200
+2,200
| +3% | +$23.6K | 0.01% | 928 |
|
2018
Q2 | $1.06M | Buy |
81,000
+20,000
| +33% | +$260K | 0.01% | 864 |
|
2018
Q1 | $672K | Buy |
+61,000
| New | +$672K | 0.01% | 998 |
|